Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Functional residual capacity is the volume of air present in the lungs at the end of passive expiration where the opposing elastic recoil forces of the lungs and chest wall are balanced. FRC is a critical concept in respiratory physiology, representing a pulmonary equilibrium point and is the sum of expiratory reserve volume (ERV) and residual volume (RV). It is essential as a clinical measurement for assessing lung mechanics and diseases, but is not a molecule, receptor, or direct therapeutic target. In summary, "Functional residual capacity" is a physiological measurement, not a molecular or therapeutic target. Its inclusion as a target molecule/receptor is an error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Functional residual capacity (FRC).